Capmatinib in patients with high-level MET-amplified advanced non-small cell lung cancer (NSCLC): results from the phase 2 GEOMETRY mono-1 study

J. Wolf; T. Overbeck; J. -Y. Han; M. Hochmair; F. De Marinis; K. Ohashi; E. F. Smit; D. Power; E. B. Garon; H. J. M. Groen; D. S. W. Tan; M. Waldron-Lynch; S. Le Mouhaer; N. Nwana; M. Giovannini; R. S. Heist

Capmatinib in patients with high-level MET-amplified advanced non-small cell lung cancer (NSCLC): results from the phase 2 GEOMETRY mono-1 study

J. Wolf, T. Overbeck, J. -Y. Han, M. Hochmair, F. De Marinis, K. Ohashi, E. F. Smit, D. Power, E. B. Garon, H. J. M. Groen, D. S. W. Tan, M. Waldron-Lynch, S. Le Mouhaer, N. Nwana, M. Giovannini, R. S. Heist

Onderzoeksoutput › Academic

Originele taal-2	English
Pagina's (van-tot)	150-151
Aantal pagina's	2
Tijdschrift	Oncology Research and Treatment
Volume	43
Nummer van het tijdschrift	SUPPL 4
Status	Published - okt.-2020

Handle.net

Permanente koppeling

Citeer dit

Wolf, J., Overbeck, T., Han, J. -Y., Hochmair, M., De Marinis, F., Ohashi, K., Smit, E. F., Power, D., Garon, E. B., Groen, H. J. M., Tan, D. S. W., Waldron-Lynch, M., Le Mouhaer, S., Nwana, N., Giovannini, M., & Heist, R. S. (2020). Capmatinib in patients with high-level MET-amplified advanced non-small cell lung cancer (NSCLC): results from the phase 2 GEOMETRY mono-1 study. Oncology Research and Treatment, 43(SUPPL 4), 150-151.

@article{431c1df110c14b15b0911324456a0abc,

title = "Capmatinib in patients with high-level MET-amplified advanced non-small cell lung cancer (NSCLC): results from the phase 2 GEOMETRY mono-1 study",

author = "J. Wolf and T. Overbeck and Han, {J. -Y.} and M. Hochmair and {De Marinis}, F. and K. Ohashi and Smit, {E. F.} and D. Power and Garon, {E. B.} and Groen, {H. J. M.} and Tan, {D. S. W.} and M. Waldron-Lynch and {Le Mouhaer}, S. and N. Nwana and M. Giovannini and Heist, {R. S.}",

year = "2020",

month = oct,

language = "English",

volume = "43",

pages = "150--151",

journal = "Oncology Research and Treatment",

issn = "2296-5270",

publisher = "KARGER",

number = "SUPPL 4",

}

Wolf, J, Overbeck, T, Han, J-Y, Hochmair, M, De Marinis, F, Ohashi, K, Smit, EF, Power, D, Garon, EB, Groen, HJM, Tan, DSW, Waldron-Lynch, M, Le Mouhaer, S, Nwana, N, Giovannini, M & Heist, RS 2020, 'Capmatinib in patients with high-level MET-amplified advanced non-small cell lung cancer (NSCLC): results from the phase 2 GEOMETRY mono-1 study', Oncology Research and Treatment, vol. 43, nr. SUPPL 4, blz. 150-151.

TY - JOUR

T1 - Capmatinib in patients with high-level MET-amplified advanced non-small cell lung cancer (NSCLC)

T2 - results from the phase 2 GEOMETRY mono-1 study

AU - Wolf, J.

AU - Overbeck, T.

AU - Han, J. -Y.

AU - Hochmair, M.

AU - De Marinis, F.

AU - Ohashi, K.

AU - Smit, E. F.

AU - Power, D.

AU - Garon, E. B.

AU - Groen, H. J. M.

AU - Tan, D. S. W.

AU - Waldron-Lynch, M.

AU - Le Mouhaer, S.

AU - Nwana, N.

AU - Giovannini, M.

AU - Heist, R. S.

PY - 2020/10

Y1 - 2020/10

M3 - Meeting Abstract

VL - 43

SP - 150

EP - 151

JO - Oncology Research and Treatment

JF - Oncology Research and Treatment

SN - 2296-5270

IS - SUPPL 4

ER -